Astrocyte Pharmaceuticals Inc.
PrivateLast Round
Grant
Jun 17, 2025
Total Funding Raised
$17.67M
Company Overview
Astrocyte Pharmaceuticals Inc. is a biotechnology company developing novel neuroprotective therapeutics for the treatment of stroke, traumatic brain injury, concussions, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrocyte Pharmaceuticals Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Astrocyte Pharmaceuticals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| VC Round | Aug 18, 2023 | ||||
| Grant | Sep 16, 2021 | ||||
| Series A | May 3, 2021 | ||||
| Grant | Sep 19, 2018 | ||||
Grant | Sep 18, 2018 |
Astrocyte Pharmaceuticals Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | VC Round, Series A, Seed |
| Dreavent Capital | VC Round |
| Nest.Bio | Seed |
| CR Ventures | Series A |
| NIH RADx | Grant |
| DeepWork Capital | VC Round, Series A |
| BrightFocus Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2025
$3M grant awarded by NIH RADx.
- Sep 16, 2021
Secured $3M from BrightFocus Foundation and others.
Astrocyte Pharmaceuticals Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Astrocyte Pharmaceuticals Inc.'s valuation, stock price, and market status.